RYBELSUS® is contraindicated in clients with a private or loved ones historical past of MTC and in patients with Many Endocrine Neoplasia syndrome type two (MEN 2). Counsel clients regarding the probable danger for MTC with the usage of RYBELSUS® and advise them of indicators of thyroid tumors (e. Rybelsus, https://weightlosspharmaceutic.com/product/rybelsus-semaglutide-14mg-tablets/